Free Trial

Icade (CDMGF) Short Interest Ratio & Short Volume

Icade logo
$22.45 0.00 (0.00%)
As of 04/24/2025

Icade Short Interest Data

Icade (CDMGF) has a short interest of 196,000 shares. This marks a 0.51% increase in short interest from the previous month. The short interest ratio (days to cover) is 1,960.0, indicating that it would take 1,960.0 days of the average trading volume of 467 shares to cover all short positions.

Current Short Interest
196,000 shares
Previous Short Interest
195,000 shares
Change Vs. Previous Month
+0.51%
Dollar Volume Sold Short
$4.40 million
Short Interest Ratio
1,960.0 Days to Cover
Last Record Date
March 31, 2025
Today's Trading Volume
0 shares
Average Trading Volume
467 shares
Today's Volume Vs. Average
0%
Short Selling Icade?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Icade and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CDMGF Short Interest Over Time

CDMGF Days to Cover Over Time

CDMGF Percentage of Float Shorted Over Time

Icade Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2025196,000 shares $4.40 million +0.5%N/A1960 $22.45
3/15/2025195,000 shares $4.11 million +0.6%N/A243.8 $21.06
2/28/2025193,900 shares $4.53 million +5.7%N/A1939 $23.34
2/15/2025183,400 shares $4.40 million +3.0%N/A1834 $24.00
1/31/2025178,100 shares $4.27 million +124.6%N/A1781 $24.00
1/15/202579,300 shares $1.76 million +66.3%N/A793 $22.23
12/31/202447,700 shares $1.06 million -19.6%N/A477 $22.23
12/15/202459,300 shares $1.44 million +26.7%N/A593 $24.22
11/30/202446,800 shares $1.12 million -0.4%N/A156 $23.84
11/15/202447,000 shares $1.36 million +2,373.7%N/A235 $29.00
10/31/20241,900 shares $55,100.00 -5.0%N/A19 $29.00
10/15/20242,000 shares $58,000.00 -50.0%N/A20 $29.00
9/30/20244,000 shares $124,000.00 +42.9%N/A20 $31.00
9/15/20242,800 shares $64,708.00 -96.7%N/A0 $23.11
8/31/202483,900 shares $1.94 million +0.8%N/A419.5 $23.11
8/15/202483,200 shares $1.85 million +1.3%N/A46.2 $22.28
7/31/202482,100 shares $1.83 million -12.2%N/A821 $22.28
7/15/202493,500 shares $2.08 million +52.8%N/A62.3 $22.28
6/30/202461,200 shares $1.87 million +2.0%N/A102 $30.61
6/15/202460,000 shares $1.84 million +2.0%N/A0 $30.61
5/31/202458,800 shares $1.80 million -68.6%N/A294 $30.61
5/15/2024187,100 shares $5.67 million No ChangeN/A311.8 $30.29
4/30/2024187,100 shares $5.05 million -18.7%N/A311.8 $27.00
4/15/2024230,200 shares $6.22 million -14.7%N/A2302 $27.00
3/31/2024269,700 shares $7.28 million -0.1%N/A899 $27.00
3/15/2024270,000 shares $7.29 million 0.0%N/A385.7 $27.00
2/29/2024270,100 shares $8.14 million +0.2%N/A300.1 $30.13
2/15/2024269,700 shares $8.79 million +5.5%N/A2697 $32.59
1/15/2024253,400 shares $9.38 million +78.8%N/A0 $37.00
12/31/2023141,700 shares $5.24 million -6.0%N/A23613.5 $37.00
12/15/2023150,700 shares $5.58 million -7.9%N/A1507 $37.00
11/30/2023163,600 shares $5.56 million +9.4%N/A0 $33.96
11/15/2023149,600 shares $5.08 million -3.6%N/A748 $33.96
10/31/2023155,100 shares $4.65 million -3.2%N/A1551 $30.01
10/15/2023160,300 shares $4.81 million -8.7%N/A400.8 $30.01
9/30/2023175,500 shares $5.62 million -4.5%N/A585 $32.01
9/15/2023183,800 shares $6.69 million -13.5%N/A919 $36.40
8/31/2023212,500 shares $7.42 million +12.3%N/A569.7 $34.90
8/15/2023189,200 shares $7.15 million +7.1%N/A630.7 $37.78
7/31/2023176,700 shares $6.66 million +0.3%N/A1767 $37.70
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
7/15/2023176,100 shares $6.64 million +10.7%N/A293.5 $37.70
6/30/2023159,100 shares $7.19 million +0.1%N/A1591 $45.17
6/15/2023159,000 shares $7.18 million +77.9%N/A1590 $45.17
5/31/202389,400 shares $4.04 million +22.1%N/A894 $45.17
5/15/202373,200 shares $3.31 million +4.3%N/A366 $45.17
4/30/202370,200 shares $3.31 million +4.3%N/A702 $47.14
4/15/202367,300 shares $3.16 million -8.2%N/A673 $46.97
3/31/202373,300 shares $3.44 million +1.2%N/A183.3 $46.97
3/15/202372,400 shares $3.55 million +10.4%N/A362 $48.98
2/28/202365,600 shares $3.42 million +0.8%N/A328 $52.21
2/15/202365,100 shares $2.76 million +13.6%N/A651 $42.42
1/31/202357,300 shares $2.43 million -1.9%N/A573 $42.42
1/15/202358,400 shares $2.48 million +18.2%N/A584 $42.42
12/30/202249,400 shares $2.10 million +1.0%N/A494 $42.42
12/15/202248,900 shares $2.07 million +1.9%N/A489 $42.42
11/30/202248,000 shares $2.04 million +11.9%N/A480 $42.42
11/15/202242,900 shares $1.82 million +1,200.0%N/A143 $42.42
10/31/20223,300 shares $117,150.00 -64.5%N/A33 $35.50
10/15/20229,300 shares $316,200.00 +12.1%N/A93 $34.00
9/30/20228,300 shares $301,871.00 +80.4%N/A41.5 $36.37
9/15/20224,600 shares $202,515.00 +21.1%N/A4.2 $44.03
8/31/20223,800 shares $185,934.00 No ChangeN/A38 $48.93
8/15/20223,800 shares $185,934.00 -2.6%N/A38 $48.93
7/31/20223,900 shares $187,200.00 +14.7%N/A4.9 $48.00
7/15/20223,400 shares $163,200.00 No ChangeN/A34 $48.00
6/30/20223,400 shares $163,200.00 No ChangeN/A17 $48.00
6/15/20223,400 shares $197,744.00 -8.1%N/A34 $58.16
5/31/20223,700 shares $215,192.00 No ChangeN/A37 $58.16
5/15/20223,700 shares $236,208.00 No ChangeN/A37 $63.84
4/30/20223,700 shares $236,208.00 -7.5%N/A37 $63.84
4/15/20224,000 shares $240,620.00 No ChangeN/A40 $60.16
3/31/20224,000 shares $240,620.00 No ChangeN/A0 $60.16
3/15/20224,000 shares $240,620.00 +8.1%N/A13.3 $60.16
2/28/20223,700 shares $246,050.00 -5.1%N/A37 $66.50
2/15/20223,900 shares $265,687.50 +3,800.0%N/A19.5 $68.13
1/31/2022100 shares $7,515.00 -93.3%N/A1 $75.15
1/15/20221,500 shares $112,725.00 -87.7%N/A3 $75.15
12/31/202112,200 shares $834,626.40 -15.9%N/A122 $68.41
12/15/202114,500 shares $1.10 million +27.2%N/A145 $76.00
11/30/202111,400 shares $866,400.00 No ChangeN/A114 $76.00
11/15/202111,400 shares $886,519.86 +1.8%N/A114 $77.76
10/29/202111,200 shares $870,966.88 -0.9%N/A56 $77.76
10/15/202111,300 shares $891,785.83 -0.9%N/A22.6 $78.92
9/30/202111,400 shares $904,020.00 No ChangeN/A57 $79.30
9/15/202111,400 shares $1.01 million +0.9%N/A114 $88.18
8/31/202111,300 shares $996,394.45 -0.9%N/A113 $88.18
8/13/202111,400 shares $1.01 million -2.6%N/A114 $88.18
7/30/202111,700 shares $1.03 million No ChangeN/A117 $88.18
7/15/202111,700 shares $998,712.00 +17.0%N/A117 $85.36
6/30/202110,000 shares $853,600.00 No ChangeN/A50 $85.36
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
6/15/202110,000 shares $929,300.00 -31.0%N/A100 $92.93
5/28/202114,500 shares $1.29 million +2.1%N/A145 $88.85
5/14/202114,200 shares $1.21 million +5.2%N/A142 $85.19
4/30/202113,500 shares $980,613.00 -53.1%N/A135 $72.64
4/15/202128,800 shares $2.09 million +2.5%N/A0 $72.64
3/31/202128,100 shares $2.04 million -9.1%N/A281 $72.64
3/15/202130,900 shares $2.24 million +20.2%N/A0 $72.64
2/26/202125,700 shares $1.87 million +497.7%N/A257 $72.64
2/12/20214,300 shares $355,092.28 -45.6%N/A43 $82.58
1/29/20217,900 shares $652,378.84 +97.5%N/A79 $82.58
1/15/2021700 shares $57,805.72 -63.2%N/A2.3 $82.58
12/31/20204,100 shares $338,576.36 +485.7%N/A41 $82.58
12/15/2020700 shares $57,805.72 -63.2%N/A2.3 $82.58
11/30/20201,900 shares $144,270.61 -57.8%N/A9.5 $75.93
11/15/20204,500 shares $325,107.45 +150.0%N/A3.8 $72.25
10/30/20201,800 shares $106,281.36 No ChangeN/A18 $59.05
10/15/20201,800 shares $106,281.36 No ChangeN/A2 $59.05
9/30/20201,800 shares $94,903.56 No ChangeN/A9 $52.72
9/15/20201,800 shares $114,297.30 No ChangeN/A4.5 $63.50
8/31/20201,800 shares $120,004.20 No ChangeN/A18 $66.67
8/14/20201,800 shares $120,004.20 No ChangeN/A18 $66.67
7/31/20201,800 shares $120,004.20 +5.9%N/A0 $66.67
7/15/20201,700 shares $113,339.00 No ChangeN/A8.5 $66.67
6/30/20201,700 shares $124,571.24 No ChangeN/A17 $73.28
6/15/20201,700 shares $124,571.24 +70.0%N/A0 $73.28
5/29/20201,000 shares $73,277.20 +900.0%N/A10 $73.28
5/15/2020100 shares $7,251.41 No ChangeN/A0.5 $72.51

CDMGF Short Interest - Frequently Asked Questions

What is Icade's current short interest?

Short interest is the volume of Icade shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 196,000 shares of CDMGF short. Learn More on Icade's current short interest.

What is a good short interest ratio for Icade?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CDMGF shares currently have a short interest ratio of 1,960.0. Learn More on Icade's short interest ratio.

Is Icade's short interest increasing or decreasing?

Icade saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 196,000 shares, an increase of 0.5% from the previous total of 195,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Icade's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "real estate" compare to Icade: NexPoint Diversified Real Estate Trust (1.33%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks.

What does it mean to sell short Icade stock?

Short selling CDMGF is an investing strategy that aims to generate trading profit from Icade as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Icade?

A short squeeze for Icade occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CDMGF, which in turn drives the price of the stock up even further.

How often is Icade's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDMGF, twice per month. The most recent reporting period available is March, 31 2025.




This page (OTCMKTS:CDMGF) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners